X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA WOCKHARDT LTD. ALEMBIC PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 22.5 -11.6 - View Chart
P/BV x 5.9 2.3 254.2% View Chart
Dividend Yield % 0.8 1.4 56.2%  

Financials

 ALEMBIC PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
WOCKHARDT LTD.
Mar-17
ALEMBIC PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs7921,129 70.1%   
Low Rs443627 70.7%   
Sales per share (Unadj.) Rs167.0363.1 46.0%  
Earnings per share (Unadj.) Rs38.2-20.4 -186.6%  
Cash flow per share (Unadj.) Rs42.0-7.0 -602.0%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %0.61.1 56.9%  
Book value per share (Unadj.) Rs84.9301.8 28.1%  
Shares outstanding (eoy) m188.52110.55 170.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.72.4 152.9%   
Avg P/E ratio x16.2-42.9 -37.7%  
P/CF ratio (eoy) x14.7-125.9 -11.7%  
Price / Book Value ratio x7.32.9 250.0%  
Dividend payout %10.5-48.9 -21.4%   
Avg Mkt Cap Rs m116,38397,063 119.9%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m4,2149,665 43.6%   
Avg. sales/employee Rs ThNM5,931.8-  
Avg. wages/employee Rs ThNM1,428.1-  
Avg. net profit/employee Rs ThNM-334.0-  
INCOME DATA
Net Sales Rs m31,48740,146 78.4%  
Other income Rs m551,143 4.8%   
Total revenues Rs m31,54241,289 76.4%   
Gross profit Rs m10,060128 7,859.2%  
Depreciation Rs m7221,489 48.5%   
Interest Rs m372,253 1.6%   
Profit before tax Rs m9,356-2,472 -378.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,160-211 -1,023.3%   
Profit after tax Rs m7,194-2,260 -318.3%  
Gross profit margin %31.90.3 10,020.5%  
Effective tax rate %23.18.5 270.3%   
Net profit margin %22.8-5.6 -405.8%  
BALANCE SHEET DATA
Current assets Rs m15,06646,160 32.6%   
Current liabilities Rs m7,67419,258 39.8%   
Net working cap to sales %23.567.0 35.0%  
Current ratio x2.02.4 81.9%  
Inventory Days Days67101 66.5%  
Debtors Days Days4194 43.2%  
Net fixed assets Rs m8,23740,165 20.5%   
Share capital Rs m377553 68.2%   
"Free" reserves Rs m15,41632,814 47.0%   
Net worth Rs m16,00533,367 48.0%   
Long term debt Rs m031,903 0.0%   
Total assets Rs m24,59489,687 27.4%  
Interest coverage x255.2-0.1 -262,786.6%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.4 286.0%   
Return on assets %29.40 -342,465.7%  
Return on equity %44.9-6.8 -663.5%  
Return on capital %58.7-0.3 -17,503.5%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283NA-   
Fx inflow Rs m17,8119,121 195.3%   
Fx outflow Rs m5,3182,133 249.3%   
Net fx Rs m12,4936,988 178.8%   
CASH FLOW
From Operations Rs m9,304-2,695 -345.3%  
From Investments Rs m-3,105-6,863 45.2%  
From Financial Activity Rs m-1,95912,545 -15.6%  
Net Cashflow Rs m4,2403,010 140.8%  

Share Holding

Indian Promoters % 74.1 74.5 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 2.3 126.1%  
FIIs % 9.1 7.7 118.2%  
ADR/GDR % 0.0 0.1 -  
Free float % 13.9 15.4 90.3%  
Shareholders   49,328 67,757 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jun 19, 2018 03:37 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS